HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 64 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,160,767 | +1.2% | 77,223,000 | -0.4% | 2.42% | +8.4% |
| Q2 2023 | $64,387,999 | +61.2% | 77,523,000 | +64.5% | 2.23% | +67.2% |
| Q1 2023 | $39,937,073 | -28.8% | 47,123,000 | -18.7% | 1.34% | -26.2% |
| Q4 2022 | $56,113,493 | +2.9% | 57,961,000 | -10.1% | 1.81% | -1.2% |
| Q3 2022 | $54,550,000 | -12.7% | 64,461,000 | -9.0% | 1.83% | -5.1% |
| Q2 2022 | $62,501,000 | +1.3% | 70,849,000 | 0.0% | 1.93% | +5.1% |
| Q1 2022 | $61,727,000 | – | 70,849,000 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 70,776,482 | $60,420,911 | 4.46% |
| Lombard Odier Asset Management (Europe) Ltd | 41,798,000 | $35,110,320 | 1.74% |
| CAMDEN ASSET MANAGEMENT L P /CA | 47,123,000 | $39,937,073 | 1.34% |
| Penn Mutual Asset Management | 1,555,000 | $1,318,197 | 1.25% |
| DAVIDSON KEMPNER PARTNERS | 66,537,000 | $56,390,573 | 1.09% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 66,537,000 | $56,390,573 | 0.96% |
| ZAZOVE ASSOCIATES LLC | 9,443,000 | $8,011 | 0.73% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,934,000 | $7,582,430 | 0.58% |
| CSS LLC/IL | 8,000,000 | $6,788,288 | 0.45% |
| READYSTATE ASSET MANAGEMENT LP | 5,000,000 | $4,262,534 | 0.40% |